# Customer Outcomes & Value Experiencing A New Monitoring Technology

> **NCT04262700** · NA · UNKNOWN · sponsor: **LifeScan Scotland Ltd** · enrollment: 170 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** LifeScan's new BGMS

## Key facts

- **NCT ID:** NCT04262700
- **Lead sponsor:** LifeScan Scotland Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-07
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-01
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04262700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04262700, "Customer Outcomes & Value Experiencing A New Monitoring Technology". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04262700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*